Patients with moderate-to-severe plaque psoriasis have lower fertility rates and higher risk of pregnancy loss than women with psoriasis.

Dr. Ron Vender discusses the late breaking study of an oral peptide to treat moderate-to-severe psoriasis at WCD2023 in Singapore.

Dr. Ron Vender summarizes a presentation about AI and digital dermatology at WCD2023 in Singapore.

Dr. Ron Vender reviews critical IPC presentations from WCD2023 in Singapore.

Dr. Ron Vender gives an overview of the International Psoriasis Council Councilor Meeting at WCD2023 in Singapore.

Ritlecitinib is promising for the treatment of adults and adolescents over the age of 12 years with severe alopecia areata, according to...

More than one-third of personal care products marked as hypoallergenic at major online retailers have been found to contain common skin...

Tildrakizumab is linked to improved QoL and sleep in patients with moderate-to-severe plaque psoriasis.